SlateStone Wealth LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,070 shares of the financial services provider’s stock after buying an additional 202 shares during the period. SlateStone Wealth LLC’s holdings in CME Group were worth $1,642,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. lifted its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares in the last quarter. Truvestments Capital LLC purchased a new stake in shares of CME Group in the third quarter valued at about $26,000. Dunhill Financial LLC lifted its holdings in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. Financial Life Planners purchased a new stake in shares of CME Group in the fourth quarter valued at about $32,000. Finally, Knuff & Co LLC purchased a new stake in shares of CME Group in the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently issued reports on CME. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Morgan Stanley raised their target price on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Royal Bank of Canada raised their target price on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 13th. Finally, Piper Sandler raised their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $238.93.
CME Group Stock Performance
Shares of CME stock opened at $258.68 on Friday. The company’s fifty day simple moving average is $242.80 and its 200-day simple moving average is $232.45. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $263.65. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $93.22 billion, a PE ratio of 26.75, a P/E/G ratio of 6.76 and a beta of 0.53.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.93%. CME Group’s payout ratio is 51.71%.
CME Group declared that its Board of Directors has authorized a stock buyback program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
Insider Buying and Selling
In other CME Group news, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 17,076 shares of company stock valued at $4,271,496 in the last quarter. Company insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Stock Analyst Ratings and Canadian Analyst Ratings
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Warren Buffett Stocks to Buy Now
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How is Compound Interest Calculated?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.